Extract from the Register of European Patents

EP About this file: EP2651357

EP2651357 - SUBLINGUAL FILMS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.02.2021
Database last updated on 01.04.2026
FormerThe patent has been granted
Status updated on  28.02.2020
FormerGrant of patent is intended
Status updated on  09.10.2019
FormerExamination is in progress
Status updated on  16.03.2018
FormerRequest for examination was made
Status updated on  22.02.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Sunovion Pharmaceuticals Inc.
84 Waterford Drive
Marlborough, MA 01752 / US
[2020/14]
Former [2017/03]For all designated states
Sunovion Pharmaceuticals Inc.
84 Waterford Drive
Marlborough, MA 01752 / US
Former [2015/30]For all designated states
Cynapsus Therapeutics Inc.
828 Richmond Street, W
Toronto, ON M6J 1C9 / CA
Former [2013/43]For all designated states
Cynapsus Therapeutics Inc.
828 Richmond St W
Toronto, ON M5J 1C9 / CA
For all designated states
Arx, LLC
400 Seaks Run Road
Glen Rock, PA 17327 / US
Inventor(s)01 / BRYSON, Nathan, John
99 Glen Road, Apt. 1
Toronto Ontario ON M4W 2V8 / CA
02 / GIOVINAZZO, Anthony, John
1302 Kestell Boulevard
Oakville Ontario ON L6H 0B9 / CA
03 / BARNHART, Scott, David
1820 Shawan Lane
York PA 17406 / US
04 / KOONS, Michael, Clinton
272 Point Circle
York PA 17406 / US
 [2013/43]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2020/14]
Former [2013/43]Høiberg A/S
St. Kongensgade 59 A
1264 Copenhagen K / DK
Application number, filing date11848299.116.12.2011
[2020/14]
WO2011US65665
Priority number, dateUS201161483864P09.05.2011         Original published format: US 201161483864 P
US20100423858P16.12.2010         Original published format: US 423858 P
[2013/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012083269
Date:21.06.2012
Language:EN
[2012/25]
Type: A1 Application with search report 
No.:EP2651357
Date:23.10.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 21.06.2012 takes the place of the publication of the European patent application.
[2013/43]
Type: B1 Patent specification 
No.:EP2651357
Date:01.04.2020
Language:EN
[2020/14]
Search report(s)International search report - published on:US21.06.2012
(Supplementary) European search report - dispatched on:EP20.06.2016
ClassificationIPC:A61K47/02, A61K9/70, A61K47/14, A61K47/38, A61K31/4045, A61K31/485, A61K31/473, A61K31/381, A61K31/428, A61K31/4415, A61K31/48, A61K31/4985, A61K31/506, A61F13/00
[2016/29]
CPC:
A61F13/00063 (EP,IL,US); A61K9/7007 (IL,US); A61K9/006 (EP,IL,KR,US);
A61J1/03 (IL,US); A61J7/0053 (IL,US); A61K31/381 (EP,IL,US);
A61K31/4045 (EP,IL,US); A61K31/428 (EP,IL,US); A61K31/4415 (EP,IL,US);
A61K31/473 (EP,IL,KR,US); A61K31/48 (EP,IL,US); A61K31/485 (EP,IL,US);
A61K31/4985 (EP,IL,US); A61K31/506 (EP,IL,US); A61K45/06 (EP,IL,US);
A61K47/02 (EP,IL,US); A61K47/10 (IL,US); A61K47/12 (IL,US);
A61K47/14 (EP,IL,US); A61K47/183 (IL); A61K47/22 (IL,US);
A61K47/36 (IL,US); A61K47/38 (EP,IL,US); A61K9/209 (IL,US);
A61P25/16 (EP,US); A61P43/00 (EP); B29C39/18 (IL,US);
B29C39/38 (IL,US); B29C43/305 (IL,US); B29C43/52 (IL,US);
B29C65/70 (IL,US); B29C66/45 (IL,US); B65D65/38 (IL,US);
A61K2300/00 (IL,US); B29K2001/00 (IL,US); B29L2007/008 (IL,US);
B29L2009/00 (IL,US); B29L2031/753 (IL,US); B29L2031/755 (IL,US) (-)
C-Set:
A61K31/4045, A61K2300/00 (EP);
A61K31/473, A61K2300/00 (EP);
A61K31/485, A61K2300/00 (EP)
Former IPC [2013/43]A61F13/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/43]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:SUBLINGUALE FILME[2013/43]
English:SUBLINGUAL FILMS[2013/43]
French:FILMS SUBLINGUAUX[2013/43]
Entry into regional phase16.07.2013National basic fee paid 
16.07.2013Search fee paid 
16.07.2013Designation fee(s) paid 
16.07.2013Examination fee paid 
Examination procedure16.07.2013Examination requested  [2013/43]
23.02.2017Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
24.04.2017Amendment by applicant (claims and/or description)
15.03.2018Despatch of a communication from the examining division (Time limit: M04)
25.07.2018Reply to a communication from the examining division
09.09.2019Cancellation of oral proceeding that was planned for 24.09.2019
24.09.2019Date of oral proceedings (cancelled)
10.10.2019Communication of intention to grant the patent
20.02.2020Fee for grant paid
20.02.2020Fee for publishing/printing paid
20.02.2020Receipt of the translation of the claim(s)
Divisional application(s)EP20167201.1  / EP3735988
EP26156140.1
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.03.2018
Opposition(s)12.01.2021No opposition filed within time limit [2021/11]
Request for further processing for:The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
24.04.2017Request for further processing filed
24.04.2017Full payment received (date of receipt of payment)
Request granted
09.05.2017Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
24.04.2017Request for further processing filed
24.04.2017Full payment received (date of receipt of payment)
Request granted
09.05.2017Decision despatched
Fees paidRenewal fee
27.12.2013Renewal fee patent year 03
29.12.2014Renewal fee patent year 04
28.12.2015Renewal fee patent year 05
27.12.2016Renewal fee patent year 06
27.12.2017Renewal fee patent year 07
31.12.2018Renewal fee patent year 08
27.12.2019Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL01.04.2020
EE01.04.2020
HR01.04.2020
LT01.04.2020
LV01.04.2020
MK01.04.2020
MT01.04.2020
RO01.04.2020
RS01.04.2020
SI01.04.2020
SK01.04.2020
SM01.04.2020
BG01.07.2020
IS01.08.2020
[2022/32]
Former [2022/28]AL01.04.2020
EE01.04.2020
HR01.04.2020
LT01.04.2020
LV01.04.2020
MT01.04.2020
RO01.04.2020
RS01.04.2020
SI01.04.2020
SK01.04.2020
SM01.04.2020
BG01.07.2020
IS01.08.2020
Former [2021/24]AL01.04.2020
EE01.04.2020
HR01.04.2020
LT01.04.2020
LV01.04.2020
RO01.04.2020
RS01.04.2020
SI01.04.2020
SK01.04.2020
SM01.04.2020
BG01.07.2020
IS01.08.2020
Former [2021/10]AL01.04.2020
EE01.04.2020
HR01.04.2020
LT01.04.2020
LV01.04.2020
RO01.04.2020
RS01.04.2020
SK01.04.2020
SM01.04.2020
BG01.07.2020
IS01.08.2020
Former [2021/09]AL01.04.2020
EE01.04.2020
HR01.04.2020
LT01.04.2020
LV01.04.2020
RO01.04.2020
RS01.04.2020
SM01.04.2020
BG01.07.2020
IS01.08.2020
Former [2021/04]AL01.04.2020
HR01.04.2020
LT01.04.2020
LV01.04.2020
RS01.04.2020
BG01.07.2020
IS01.08.2020
Former [2020/51]HR01.04.2020
LT01.04.2020
LV01.04.2020
RS01.04.2020
BG01.07.2020
IS01.08.2020
Former [2020/50]HR01.04.2020
LT01.04.2020
LV01.04.2020
BG01.07.2020
IS01.08.2020
Former [2020/47]LT01.04.2020
BG01.07.2020
IS01.08.2020
Former [2020/46]BG01.07.2020
IS01.08.2020
Former [2020/39]BG01.07.2020
Documents cited:Search[IP] WO2010144817  (ADAGIO PHARMACEUTICALS LTD et al.) [IP] 1-15 * the whole document * * page 1, line 5 - line 7 * * page 3, line 27 - page 5, line 24 * * page 11, line 21 - line 28 * * examples 1-11 * * claims 1-45 *
 [A] WO9826763  (LOHMANN THERAPIE SYST LTS et al.) [A] 1-15 * page 1, line 1 - line 5 * * page 4, line 3 - line 22 * * examples 1,2 * * claims 1-3,7,8 *
 [A] WO2006120412  (AMARIN PHARMACEUTICALS IRELAND et al.) [A] 1-15 * page 1, line 6 - line 9 * * page 3, line 19 - line 28 * * page 4, line 10 - page 5, line 9 * * page 10, line 25 - page 12, line 11 * * example 1 * * claims 1-14 *
International search[Y] US2005031677  (PATHER S INDIRAN et al.) [Y]
 [Y] US2010035886  (CINCOTTA ANTHONY H et al.) [Y]
 [Y] US2008124381  (BARNHART SCOTT D et al.) [Y]
 [YP] US2011111011  (GIOVINAZZO ANTHONY JOHN et al.) [YP]
 [YP] US2011033542  (MYERS GARRY L et al.) [YP]
by applicantWO2010144817
 WO9826763
 WO03080074
 US4687773
 WO2005099702
 WO2009052421
 US2006210610
 US2001006677
 US4746508
 US4540602
 US5145684
 US5518187
 US5718388
 US5862999
 US5665331
 US5662883
 US5560932
 US5543133
 US5534270
 US5510118
 US5470583
 US6976647
 EP0498482
 US3559895
 US42385810
 US201161483864
   VAN LAAR T., CNS DRUGS, vol. 17, 2003, pages 475
   KOLLER ET AL., NEUROLOGY, vol. 62, no. 4, 2004, pages S22 - S31
   DEFFOND ET AL., J. NEUROL. NEUROSURG. PSYCHIATRY, vol. 56, 1993, pages 101
   PRIETZ ET AL., J. NEUROL. NEUROSURG. PSYCHIATRY, vol. 65, 1998, pages 709
   BORGMAN ET AL., J. MED. CHEM., vol. 19, 1976, pages 717
   ATKINSON ET AL., J. PHARMA. SCI., vol. 65, 1976, pages 1685
   CAMPBELL ET AL., NEUROPHARMACOLOGY, vol. 21, 1982, pages 953
   KEARY, CARBOHYDRATE POLYMERS, vol. 45, 2001, pages 293
   REHSE ACHIVES DES PHARMAZIE, vol. 7, 1969, pages 488
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.